FDA Approved: OPDUALAG — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA has approved a supplemental application for OPDUALAG (nivolumab and relatlimab-rmbw) submitted by E.R. Squibb & Sons, L.L.C. The document indicates the stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (nivolumab)

Snippet

SUPPL AP for OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)